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This discussion focuses on the dynamic nature ofthree chronic congenital infections ofman,
namely those caused by cytomegaloviruses, rubella virus, and Toxoplasma gondii. The spectra
ofthe fetal infection aredescribed and the risks associated with the acute and chronic phases of
the fetal infections are contrasted. Because of their frequency and subtlety, emphasis is placed
on the late-appearing sequelae which are associated with the persistent and/or recurring
aspects of these infections.
The risks ofcongenitally acquired infections will be discussed here in terms of the
nature ofdisease in the fetus, infant, and child caused bycytomegaloviruses (CMV),
rubella virus, and Toxoplasmagondii. Although these organisms have relatively low
pathogenicity, even for the human conceptus, they can produce acute, multi-organ
system disease in the fetus. More commonly, however, the intrauterine infection is
subclinical but with a variable tendency to produce subtle, late-appearing defects in
association with persistent and/or recurring infections long after delivery. Because
of their frequency, the subclinical infections are equally as important from a public
health standpoint as the clinically apparent ones.
CYTOMEGALOVIRUS
CMV is the most common cause ofintrauterine infection in man, occurring in one
percent (0.5-2.3 percent) of all live births throughout the world [1,2]. It is more
prevalent in lower socioeconomic sectors of developed nations and in developing
countries. About five percent of the infected infants have typical cytomegalic inclu-
sion disease, another five percent may have atypical clinical involvement, and 90
percent are born with subclinical infection [2]. Irrespective ofthe nature ofthe infec-
tion, CMV is usually excreted for months from the nasopharnyx and for years into
the urine following in utero involvement [3]. The more severe types of this infection
are associated with increased antigenic stimulation in the form of higher levels of
virus production in the early months following delivery and increased immunologic
stimulation, as measured by accelerated immunoglobulin development (especially
IgM) with higher levels of antibody and immune complex formation [3,4].
Although there may be infection ofmultiple organs, cytomegalic inclusion disease
of the newborn is typically characterized by involvement of the reticulo-endothelial
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and central nervous systems [5,6]. Clinically, some combination of petechiae, hepa-
tosplenomegaly, and jaundice are seen in all of the infected patients. In addition, a
significant prenatal insult is indicated by the occurrence of microcephaly, in-
trauterine growth retardation, and prematurity in approximately 50 percent of
cases. These latter defects seldom occur as isolated ones. From the laboratory stand-
point, the following are found in decreasing order of frequency: increased cord
serumIgM (> 20 mg/100 ml), atypical lymphocytosis (> 5 percent), elevated SGOT
(> 80 uU/ml), thrombocytopenia (< 100,000 platelet/cu mm), conjugated hyper-
bilirubinemia (indirect serum bilirubin > 2 mg/100 ml) and increased cerebrospinal
fluid protein (> 120 mg/100 ml). These laboratory abnormalities are found in from
50-90 percent of the cases. Mortality rates can range as high as 30 percent with
severe typical disease in the young infant [5] or the fetal infection may be fulminant
with obvious multiple organ system involvement at birth or may have run its course
in utero and present as isolated central nervous system involvement, such as
microcephaly without other findings. At the other end of the spectrum, the fetal in-
fection may have minimal manifestations that are easily overlooked or misdiagnosed
in early infancy, but which still result in significant central nervous system damage
in later life. With cytomegalic inclusion disease, the outlook for normal development
is bleak since upward of 90 percent of infected infants will develop significant men-
tal and/or perceptual defects in the first two years after delivery [5,6]. Microcephaly,
usually coupled with severe intellectual deficits and/or neuromuscular disorders
(seizures, paresis, and spasticity), is observed in 80 percent or more of the cases. In
addition, severe hearing loss and ocular abnormalities (chorioretinitis and optic
atrophy) occur in 25 to 30 percent, often in association with the central nervous
system defects.
In infants with subclinical infection, the outlook is much better. Nevertheless,
about ten percent of these infants will develop severe degrees of deafness which can
appear de novo in later life, usually within the first two years, and which may be
progressive [7]. In as yet an undetermined number, the subclinical infection may be
associated with the later development of minimal brain dysfunction syndromes,
manifested as intellectual deficits and behavioral disorders [8]. Recently, we have
observed striking dental defects, simiilar to those seen with congenital rubella, in
association with congenital CMV infection.
Conservatively estimating a one percent incidence for congenital CMV infection
and three million live births per year in the U.S.A., about 3000 infants will become
severely handicapped annually as a result of typical or atypical cytomegalic inclusion
disease [2]. Another 3000 or more will develop significant hearing and mental
deficits as a result of the subclinical infection. Hence, as emphasized by Weller, the
year-in-and-year-out toll of handicaps resulting from endemic CMV infection far
exceeds that produced by rubella virus, where the major impact is more dramatic but
limited to epidemic cycles [1].
The reason for the high incidence of congenital CMV infection compared to other
chronic intrauterine infection is that the virus can be transmitted in utero not only
with primary maternal infection but also in the course of recurrent maternal infec-
tion resulting from reactivation of latent virus in immune women [2,9]. With the
other infections, intrauterine involvement occurs almost exclusively with primary
maternal infection. Recent data indicate, however, that primary maternal CMV in-
fection is associated with the more virulent form of fetal infection [10]. Whether
recurrent maternal infection can result in subtle infection with late-appearing se-
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quelae is yet to be determined, but is an important consideration with respect to use
of live vaccines for the control of congenital CMV infection.
RUBELLA
Unlike CMV, congenital rubella is believed to occur only with primary maternal
infection when virus in the circulation can infect the placenta and subsequently seed
the fetus [11]. Although reinfection can occur in a small percentage of cases follow-
ing natural infection and a higher percentage following vaccination [12], maternal
immunity is thought to protect against in utero transmission of virus.
There are no really good estimates for the incidence of congenital rubella for
many reasons. Rubella is often subclinical in the mother and baby, may mimic other
infections in the mother, and occurs in epidemic waves which are variable as regards
their occurrence, size, and virulence [11]. In the U.S.A., widespread vaccination of
children, the major purveyors of rubella in the past, has altered the pattern of
epidemicity favorably, but has resulted in women of childbearing ages becoming the
main target for infection in recent years [13]. Widespread epidemics still occur in
most other areas of the world where the vaccination programs are focused on fe-
males in the childbearing years. Under these circumstances, congenital rubella re-
mains a major problem. In the U.S.A., rubella remains a significant problem since
women in the childbearing ages remain susceptible, as they were too old to be im-
munized when the vaccine was first introduced.
The fetal infection is persistent with viral excretion (nasopharynx, urine, conjunc-
tive) commonly demonstrable for the first few months after delivery, but with
diminishing frequency thereafter. During gestation only a few or many fetal organs
can become infected. Consequently, congenital rubella results in a wide spectrum of
disease in the young infant, favoring subclinical involvement in the early months of
life[1 1,14]. Since rubella virus can infect the fetus in the earliest stages of gestation
it classically results in disturbances of embryogenesis. However, continuing viral
replication can cause chronic damage in later gestation and well into the postnatal
period, likely through vascular insufficiency and subtle cytopathology rather than
inflammatory damage, which is more characteristic of the other chronic congenital
infections[11].
Even among newborns with clinically evident congenital rubella, the range of
disease is broad[11,15]. Although there may be gross anatomical defects in many
organ systems, they are relatively rare except for the cardiovascular abnormalities
with characteristic disturbances of the pulmonary arterial system, the ductus, and
the aortic isthmus. Other common defects which probably result from chronic infec-
tion include: intra- and extrauterine growth retardation, hepatosplenomegaly,
thrombocytopenia with purpura, adenopathy, active encephalitis, retinopathy,
deafness, interstitial pneumonia, cataracts, and bony radiolucencies. Cardiac
defects with early heart failure, rapidly progressive hepatitis, extensive men-
ingoencephalitis, fulminant interstial pneumonia, and major anatomical defects
carry a poor prognosis for survival. Many of the defects are masked during the neo-
natal period only to become progressive in the ensuing months. Cardiac defects,
pneumonia, hepatitis, encephalitis, and eye defects are in this category. Although 70
percent of young infants with congenital rubella may be subclinically infected, evi-
dent disease including most commonly isolated hearing defects will develop in 70
percent or more of them within the first five years after delivery [14].
Certain sequelae of congenital rubella may not appear until many years after
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delivery [11]. Deafness, the most common defect of congenital rubella, is easily
missed in young infants. However, it may appear de novo in later childhood and can
even be progressive like that seen following congenital CMV infection. Language,
learning, and psychiatric disorders resulting from the central nervous system in-
volvement may also be quite delayed in onset. Late-appearing endocrine abnormali-
ties include diabetes mellitus and, rarely, thyroid dysfunction, growth hormone
disturbances, and precocious puberty. Visual and dental abnormalities frequently
appear late. In addition, active infection of the central nervous system may recur in
late childhood, manifesting itself as a subacute progressive panencephalitis. Exactly
how rubella, an RNA virus, persists in the human host long after viral excretion
disappears is a moot point but an intriguing one for future research.
Gestational age at the time of the maternal infection is the most important factor
influencing intrauterine transmission and virulence of the fetal infection. At least
during the first half of gestation the rate of fetal infections and its virulence are in-
versely related to gestational age [11]. The infection is more common and severe when
acquired in the first ten weeks of gestation than when acquired later. Recent data,
however, indicate that rubella virus may be transmitted in utero in late gestation
much more frequently than previously thought [16]. Whether there is a pathologic
potential associated with late gestational transmission is unknown. Significant
disease is apparently not a problem with natal and early postnatal transmission.
TOXOPLASMOSIS
Congenital toxoplasmosis, rather than being caused by a virus, results from fetal
infection by the protozoan parasite, Toxoplasma gondii [17]. The only natural hosts
for this organism are members of the feline family. All other animals, including
man, are secondary hosts who experience end-stage infection by trophozoites with
the formation of infectious pseudocysts in muscle and certain viscera which remain
infectious for many years. Pregnant women, then, are infected upon consumption
of undercooked fresh meat or upon exposure to infectious oocytes excreted by in-
fected cats, usually acutely infected kittens. In the U.S.A., the incidence of con-
genital toxoplasmosis varies from one per 1000 to 3000 live births. It is much more
prevalent in Europe due to a greater consumption of rare meat and in areas where
there are large populations of cats and poor sanitation. Infection of the product of
conception results from primary, usually subclinical, maternal infection much as it
does with rubella. Unlike CMV, maternal immunity protects against intrauterine
transmission of the parasite.
As with the other infections discussed here, congenital toxoplasmosis is usually
subclinical; only ten percent or so of infected newborns have clinically evident
disease [17]. Two forms of the disease have been described: a neurologically domi-
nant variety, which is the most common form, and a disseminated variety with
multiple organ system involvement. Essentially, acute disease in the newborn
resembles that described above for CMV. There is a greater tendency for prematuri-
ty, chorioretinitis, and hydrocephalus with generalized intracranial calcifications
with congenital toxoplasmosis. Indeed, these two infections almost always have to
be distinguished by laboratory means. Prognosis for normal central nervous system
and perceptual development is very poor with clinically evident disease in the
newborn, as it is with CMV. For this reason, various forms of therapy have been ad-
vocated for congenital toxoplasmosis, but their usefulness is yet to be adequately
documented [17].
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Subclinical congenital toxoplasmosis, though far less common, is more dangerous
than silent congenital CMV infection. Almost all infected infants will eventually
develop serious or potentially serious defects, the most common of which is
chorioretinitis [18]. Chorioretinitis may be present at birth as an isolated defect
which is often overlooked. More often it develops months to years after delivery and
can be progressive. Visual acuity is in jeopardy in virtually all individuals with con-
genital toxoplasma infection. Central nervous system disease, including deterior-
ating intellectual development, may not become evident for many months or years
following delivery. Indeed, cerebrospinal fluid abnormalities (elevated protein levels
and low-grade lymphocytosis) are often observed with congenital toxoplasmosis
which is otherwise subclinical. Deafness and precocious puberty can also occur as
late sequelae of subclinical infection.
As with rubella, gestational age is the major determinant ofintrauterine transmis-
sion and virulence ofthe fetal infection with toxoplasma [19]. Intrauterine transmis-
sion is inversely related to gestational age. Thus, fetal infection occurs much more
frequently following maternal infection acquired from mid-gestation to term than
when acquired earlier. However, virulence of the fetal infection is inversely related
to gestational age. Severe fetal disease occurs almost exclusively with maternal infec-
tion acquired in the first or early second trimesters. Whether the suggested dif-
ferences in the virulence among strains of toxoplasma contribute to the broad spec-
trum of disease seen in the infected offspring is yet to be resolved.
Hopefully, this brief discussion has focused attention on the dynamic nature of
the common chronic intrauterine infection and will alert the physician to the need
for long-term assessment of the associated problems. For maximal benefit to the in-
fected child, recognition and management of the late sequelae is equally as impor-
tant as treatment of acute disease in the young infant.
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